TD Cowen analyst Charles Rhyee lowered the firm’s price target on Charles River to $228 from $260 and keeps a Hold rating on the shares. The firm said following a soft 1Q DSA print questions around the 2H ramp implied in the company’s adj.usted EPS guide remain. While strong 1Q biotech funding makes a 2H inflection likely, Cowen sees its guide requiring SA to see near full capacity utilization in 3Q/4Q which remains uncertain.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL: